XML 37 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended 143 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Cash flow from operating activities:      
Net loss $ (1,616,993) $ (2,101,525) $ (30,314,408)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 9,385 311 168,790
Vested stock options and warrants 273,420 1,329,735 7,471,162
Equity instruments issued for management and consulting 62,917 67,230 6,091,975
Stock-based registration payments 0 0 355,124
Capital contributions resulting from waivers of debt 0 0 476,398
Amortization of debt discount 0 28,521 756,497
(Gain) loss on valuation of equity-linked instruments (11,468) (19,422) (797,118)
Changes in assets and liabilities:      
Accounts receivable 33,391 (57,001) (63,854)
Inventories (269,392) 3,762 (391,567)
Prepaid expense and other assets (62,057) (28,600) (122,645)
Notes payable to shareholders 0 0 (14,957)
Accounts payable 40,535 (77,831) 2,188,407
Accrued expenses (212,180) (100,465) 2,282,057
Deferred Revenue 0 15,000 69,000
Net cash used in operating activities: (1,752,443) (940,285) (11,845,140)
Cash flow from investing activities:      
Purchase of fixed assets (72,377) 0 (247,396)
Purchase of intangibles (14,226) 0 (210,076)
Net cash used in investing activities (86,603) 0 (457,472)
Cash flow from financing activities:      
Proceeds from long-term and convertible debt 20,000 300,000 3,955,209
Repayment of convertible debt 0 0 (250,000)
Principal payments on debt (300,000) 0 (375,667)
Issuance of preferred stock 2,055,000 0 2,055,000
Issuance of common stock 92,831 1,000,000 7,048,808
Net cash provided by (used in) financing activities 1,867,831 1,300,000 12,433,350
Net increase (decrease) in cash 28,785 359,715 130,738
Cash at beginning of period 101,953 13,139 0
Cash at end of period 130,738 372,854 130,738
Non cash transactions:      
Conversion of debt to accrued liabilities 0 415,775 515,775
Common stock issued for accrued interest/bonus 694,500 12,225 1,315,339
Conversion of accounts payable to convertible debt 0 0 546,600
Common stock issued to satisfy debt 0 22,325 3,538,935
Stock/warrant issued to satisfy accounts payable/Liabilities $ 0 $ 0 $ 539,165